Accuro 3S for Spinal Anesthesia

This trial aims to test the Accuro 3S, a new device that provides real-time guidance for administering spinal or epidural anesthesia. The researchers seek to determine if this device can match the accuracy and safety of X-rays without the associated radiation. It may suit patients requiring spinal or epidural anesthesia for childbirth or surgery, provided they have no skin issues or allergies related to the procedure. As an unphased trial, this study offers patients the chance to contribute to innovative research that could enhance anesthesia safety and accuracy.

The trial information does not specify whether you need to stop taking your current medications. However, if you are using anti-coagulants (blood thinners), you may not be eligible to participate.

Previous studies have shown positive safety results for the Accuro 3S device. Research indicates that the device is effective and safe for assisting doctors with spinal and epidural procedures. It employs advanced ultrasound technology to help doctors accurately locate the spot for needle placement, reducing reliance on other imaging methods like X-rays.

Most treatments for spinal anesthesia rely on standard techniques that can sometimes be challenging due to the need for precise needle placement. However, the Accuro 3S is unique because it enhances these standard methods with neuraxial guidance. This device uses real-time imaging to help guide the needle's trajectory without relying on contrast or exposing patients to radiation. Researchers are excited because this method aims to improve accuracy and safety, potentially making spinal and epidural procedures more effective and less prone to complications.

Studies have shown that the Accuro 3S device significantly improves the chances of successfully inserting spinal and epidural needles on the first try, achieving a 72.5% success rate compared to 40% with traditional methods. This increases the likelihood of correct needle placement on the first attempt. The device also reduces the risk of complications such as tingling or numbness during the procedure. In some cases, particularly with patients who are more challenging to treat, the Accuro device increased success rates by up to 26%. The Accuro 3S uses ultrasound technology to guide doctors, eliminating the need for X-rays and making the process safer and more convenient. Participants in this trial will receive spinal or epidural procedures using the Accuro 3S for neuraxial guidance alongside standard care techniques.¹²³⁵⁶